![John Dawson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Dawson
Président chez
Virocell Biologics Ltd.
Profil
John Andrew Dawson is currently the Chairman at Virocell Biologics Ltd., the Director at Oxford Biomedica (UK) Ltd., and the Non Executive Director at Chuangsheng Qiao Kang Pharmaceutical Co., Ltd. He previously worked as an Executive Director at Oxford Biomedica Plc from 2008 to 2022, Director-Finance & Administration at Serono Laboratories (UK) Ltd. in 1996, Independent Non-Executive Director at Ergomed Plc in 2022, CFO & Head-Business Development at Cephalon, Inc. from 1996 to 2007, and Member-Supervisory Board at PAION AG from 2014 to 2019.
Postes actifs de John Dawson
| Sociétés | Poste | Début |
|---|---|---|
Oxford Biomedica (UK) Ltd.
 Oxford Biomedica (UK) Ltd. BiotechnologyHealth Technology Develops novel gene therapy products and treatment for cystic fibrosis | Directeur/Membre du Conseil | - |
Virocell Biologics Ltd.
 Virocell Biologics Ltd. BiotechnologyHealth Technology Manufactures viral vectors and gene therapies clinical devices | Président | - |
Chuangsheng Qiao Kang Pharmaceutical Co., Ltd.
 Chuangsheng Qiao Kang Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Develops ocular therapeutics and treatments for rare diseases | Directeur/Membre du Conseil | - |
Anciens postes connus de John Dawson
| Sociétés | Poste | Fin |
|---|---|---|
| OXFORD BIOMEDICA PLC | Directeur Général | 28/01/2022 |
| PAION AG | Directeur/Membre du Conseil | 22/05/2019 |
Cephalon, Inc.
 Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Directeur Financier/CFO | 01/01/2007 |
Serono Laboratories (UK) Ltd. | Directeur Financier/CFO | 01/01/1996 |
| ERGOMED | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
61
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Cephalon, Inc.
Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
PAION AG
 PAION AG Pharmaceuticals: MajorHealth Technology Operates as a holding company whose subsidiaries develops and commercializes specialty pharmaceutical products | Health Technology |
Oxford Biomedica Plc
 Oxford Biomedica Plc BiotechnologyHealth Technology Operates as a contract development and manufacturing organization which provides viral vectors to pharmaceutical and biotechnology clients in cell and gene therapy fields | Health Technology |
Oxford Biomedica (UK) Ltd.
Oxford Biomedica (UK) Ltd. BiotechnologyHealth Technology Develops novel gene therapy products and treatment for cystic fibrosis | Health Technology |
Ergomed Plc
 Ergomed Plc BiotechnologyHealth Technology Engages in research and development of drugs for oncology & rare diseases | Health Technology |
Serono Laboratories (UK) Ltd. | |
Virocell Biologics Ltd.
Virocell Biologics Ltd. BiotechnologyHealth Technology Manufactures viral vectors and gene therapies clinical devices | Health Technology |
Chuangsheng Qiao Kang Pharmaceutical Co., Ltd.
Chuangsheng Qiao Kang Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Develops ocular therapeutics and treatments for rare diseases | Commercial Services |
